Bayesian transition models for ordinal longitudinal outcomes.

Publication date: Aug 15, 2024

Ordinal longitudinal outcomes are becoming common in clinical research, particularly in the context of COVID-19 clinical trials. These outcomes are information-rich and can increase the statistical efficiency of a study when analyzed in a principled manner. We present Bayesian ordinal transition models as a flexible modeling framework to analyze ordinal longitudinal outcomes. We develop the theory from first principles and provide an application using data from the Adaptive COVID-19 Treatment Trial (ACTT-1) with code examples in R. We advocate that researchers use ordinal transition models to analyze ordinal longitudinal outcomes when appropriate alongside standard methods such as time-to-event modeling.

Concepts Keywords
Longitudinal Bayes Theorem
Med Bayesian modeling
Models clinical trials
Research COVID-19
Rich COVID-19 Drug Treatment
Humans
Longitudinal Studies
Models, Statistical
ordinal longitudinal outcomes
SARS-CoV-2
transition models

Semantics

Type Source Name
disease MESH COVID-19
disease VO efficiency
disease VO time

Original Article

(Visited 3 times, 1 visits today)